We demonstrated that the patients with ESCC who had elevated STX3 mRNA and protein expression levels experienced significantly shorter OS, suggesting that STX3, either at the genetic or protein level, could serve as a prognostic marker in ESCC following esophagectomy. This evidence concerns the gene STX3 and esophageal squamous cell carcinoma.